Greenwich LifeSciences, Inc. (GLSI)
GLSI Stock Price Chart
Explore Greenwich LifeSciences, Inc. interactive price chart. Choose custom timeframes to analyze GLSI price movements and trends.
GLSI Company Profile
Discover essential business fundamentals and corporate details for Greenwich LifeSciences, Inc. (GLSI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
25 Sept 2020
Employees
4.00
CEO
Snehal S. Patel
Description
Greenwich LifeSciences, Inc. functions as a clinical-stage biopharmaceutical company, dedicated to developing innovative cancer immunotherapies. These treatments are primarily focused on breast cancer and other HER2/neu-positive malignancies. Its flagship therapeutic candidate is GP2, an immunotherapy which has successfully completed its Phase IIb clinical trials. This drug is designed to prevent the recurrence of breast cancer in patients who have already undergone surgical removal of the tumor. Founded in 2006 and based in Stafford, Texas, the company was formerly known as Norwell, Inc. until it rebranded to Greenwich LifeSciences, Inc. in March 2018.
GLSI Financial Timeline
Browse a chronological timeline of Greenwich LifeSciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
EPS estimate is -$0.34.
Earnings released on 3 Jun 2026
EPS came in at -$0.39 falling short of the estimated -$0.33 by -18.18%.
Earnings released on 31 Mar 2026
EPS came in at -$0.32 matching the estimated -$0.32.
Earnings released on 14 Nov 2025
EPS came in at -$0.30 matching the estimated -$0.30.
Earnings released on 14 Aug 2025
EPS came in at -$0.30 falling short of the estimated -$0.24 by -25.00%.
Earnings released on 20 May 2025
EPS came in at -$0.25 falling short of the estimated -$0.24 by -4.17%.
Earnings released on 15 Apr 2025
EPS came in at -$0.61 falling short of the estimated -$0.21 by -190.48%, while revenue for the quarter reached $3.61k .
Earnings released on 14 Nov 2024
EPS came in at -$0.20 surpassing the estimated -$0.21 by +4.76%.
Earnings released on 14 Aug 2024
EPS came in at -$0.20 matching the estimated -$0.20.
Earnings released on 20 May 2024
EPS came in at -$0.19 surpassing the estimated -$0.20 by +5.00%.
Earnings released on 15 Apr 2024
EPS came in at -$0.21 falling short of the estimated -$0.20 by -5.00%, while revenue for the quarter reached $5.42k .
Earnings released on 19 Oct 2023
EPS came in at -$0.19 surpassing the estimated -$0.22 by +13.64%.
Earnings released on 21 Aug 2023
EPS came in at -$0.13 surpassing the estimated -$0.23 by +43.48%.
Earnings released on 22 May 2023
EPS came in at -$0.17 surpassing the estimated -$0.23 by +26.09%.
Earnings released on 31 Mar 2023
EPS came in at -$0.22 falling short of the estimated -$0.18 by -22.22%.
Earnings released on 14 Nov 2022
EPS came in at -$0.18 surpassing the estimated -$0.19 by +5.26%.
Earnings released on 15 Aug 2022
EPS came in at -$0.06 surpassing the estimated -$0.19 by +68.42%.
Earnings released on 20 May 2022
EPS came in at -$0.15 surpassing the estimated -$0.19 by +21.05%.
Earnings released on 21 Mar 2022
EPS came in at -$0.18 falling short of the estimated -$0.07 by -157.14%.
Earnings released on 15 Nov 2021
EPS came in at -$0.07 falling short of the estimated -$0.06 by -16.67%.
Earnings released on 13 Aug 2021
EPS came in at -$0.06 .
GLSI Stock Performance
Access detailed GLSI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
